The contribution of environmental factors to pancreatic islet damage in type 1 diabetes remains poorly understood. In this study, we crossed mice susceptible to type 1 diabetes, where parental male (CD8 C T cells specific for IGRP [206][207][208][209][210][211][212][213][214] ; NOD8.3) and female (NOD/ShiLt) mice were randomized to a diet either low or high in AGE content and maintained on this diet throughout pregnancy and lactation. After weaning, NOD8.3 C female offspring were identified and maintained on the same parental feeding regimen for until day 28 of life. A low AGE diet, from conception to early postnatal life, decreased circulating AGE concentrations in the female offspring when compared to a high AGE diet. Insulin, proinsulin and glucagon secretion were greater in islets isolated from offspring in the low AGE diet group, which was akin to age matched non-diabetic C57BL/6 mice. Pancreatic islet expression of Ins2 gene was also higher in offspring from the low AGE diet group. Islet expression of glucagon, AGEs and the AGE receptor RAGE, were each reduced in low AGE fed offspring. Islet immune cell infiltration was also decreased in offspring exposed to a low AGE diet. Within pancreatic lymph nodes and spleen, the proportions of CD4
Introduction
Type 1 diabetes is a chronic autoimmune disease which generally manifests in early life. Over the past three decades, the global incidence of type 1 diabetes has increased, 1 particularly in individuals without any known high-risk genotypes and in infants. 2, 3 This suggests that environmental factors in utero 4, 5 or in early life may contribute to pancreatic islet autoimmunity and promote destruction of insulin-producing b-cells later in life. 1 Indeed, autoantibodies to common pancreatic islet antigens are already measurable during the first two years of life in children who subsequently develop type 1 diabetes. 6 A number of longitudinal studies in infants at risk of developing type 1 diabetes have provided insight into the contribution of environmental factors that could act as precipitating events. [7] [8] [9] [10] [11] Nutritional factors have been of interest in these prospective birth cohorts for over a decade. For instance, the Trial to Reduce IDDM in the Genetically at-Risk (TRIGR) study in Finland 11 and the Diabetes and Autoimmunity Study in the Young (DAISY) in Colorado, 3 suggested that early or late exposure to certain foods may alter islet autoimmunity and increase the risk for type 1 diabetes. However, the multicenter German BABYDIAB study found only weak associations between infant feeding and the risk of developing type 1 diabetes, 12 which may relate to variability in infant nutrition between the countries where individuals were recruited. 13 Mirroring the pathogenesis seen in humans, the susceptibility to type 1 diabetes development in the non-obese diabetic (NOD/ShiLt) and transgenic NOD8.3 mouse can also be influenced by environmental factors. [14] [15] [16] [17] [18] Protein modifications termed advanced glycation end products (AGEs) are environmental factors which, together with modifications in their receptor, RAGE, associate with risk for islet autoimmunity and type 1 diabetes development. [19] [20] [21] AGEs are made endogenously 22 and may be absorbed from dietary sources. 23, 24 Circulating levels of AGEs appear to correlate between mother and baby, 25 suggesting maternal transmission of AGEs to the fetus. Previous studies have identified that decreasing dietary AGE intake can improve glucose homeostasis in individuals with type 2 diabetes 26 and in healthy, but overweight, adults. 27 In type 1 diabetes, dietary reduction in AGE intake across generations of NOD/ShiLt mice suppressed diabetes incidence and improved glucose tolerance, 28 confirming previously described effects of AGEs on murine islet function, 29, 30 islet infiltration, 29 and glucose homeostasis 29, 31, 32 in the NOD/ShiLt mouse and the type 2 diabetic db/db mouse. Together, these data highlight the importance of excessive AGEs as risk factors that impact on metabolic health in diabetes.
RAGE, which is expressed on cells from the innate and adaptive immune system, including antigen presenting cells 33, 34 and T cells [35] [36] [37] [38] allows for interaction with a number of ligands, including AGEs. 19 Manipulating AGE concentrations has been shown to affect macrophage proliferation in vitro, 39 CD4 C T cell proportions and their ability to proliferate in response to b-cell antigens in adult NOD/ShiLt mice. 28 These, and other studies reviewed elsewhere, 19 emphasize interplay of RAGE and its ligands in immunology and autoimmunity that is yet to be fully appreciated.
In this study, we explored the influence of low and high dietary AGE exposure from conception to early postnatal life in islet function and immune cell infiltration in a transgenic mouse strain susceptible to accelerated type 1 diabetes development. We fed IGRP 206-214 NOD8.3 male and NOD/ShiLt female mating pairs a diet that was either low or high in AGE content and after weaning, maintained the NOD8.3 female offspring on the same parental diet until sacrifice at day 28. We examined effects of both dietary exposures on glucose homeostasis, pancreatic histopathology, static ex vivo hormone secretion and immune cell subsets within lymphoid tissues in the NOD8.3 female offspring.
Results

Biochemical parameters
Offspring exposed to a low AGE (LAGE) diet, from conception until the study end at day 28 of life, had lower circulating AGE concentrations (carboxymethyllysine; CML) as compared to offspring exposed to a high AGE (HAGE) diet (p D 0.03; Table 1 ). At the study end, fasting plasma insulin, proinsulin, glucagon and blood glucose concentrations, as well as body weight were not different between groups (Table 1) .
Exposure to low dietary AGEs from conception to early postnatal life increases islet hormone secretion ex vivo Type 1 diabetes is characteristically preceded by defects in insulin secretion. [40] [41] [42] Pancreatic islets were isolated and exposed to various concentrations of glucose to stimulate insulin secretion and measure glucagon secretion. Insulin secretion from LAGE islets was 4-fold higher at both 2.8 mM (p D 0.002; Fig. 1A ) and 20 mM (p D 0.02; Fig. 1B ) glucose concentrations when compared to islets from HAGE offspring. The ratio of insulin released between stimulated and basal glucose concentrations (stimulation index) did not differ between treatment groups (Fig. 1C) . At the end of the secretion assay, islets isolated from LAGE offspring had a more variable insulin content compared to that of HAGE offspring, but no significant differences were seen between groups (Fig. 1D) . Stimulated insulin secretion and total insulin content from islets from NOD8.3 offspring exposed to a low AGE diet was more comparable to nondiabetes susceptible control mice than from NOD8.3 offspring exposed to a high AGE diet (Fig. 1B-D) . Similar to that of insulin, proinsulin secretion from LAGE islets after 2.8 mM (Fig. 1E ) and 20 mM (Fig. 1F ) glucose concentrations showed a 4-fold increase compared to HAGE islets. While the majority of LAGE islets tended to have a reduced proinsulin/ insulin ratio compared to HAGE islets, this effect was not significant (Fig. 1G) . Islet proinsulin content after acid ethanol treatment did not differ between groups (Fig. 1H) . Failure of the glucagon response to hypoglycemia, 43 and insufficient glucagon suppression during hyperglycemia are observed in individuals with type 1 diabetes. 44 Glucagon secretion was elevated during low glucose concentrations in islets isolated from LAGE offspring (p D 0.02; Fig. 1I ) and reduced by 3.5-fold under high glucose concentrations (Fig. 1J) . Although the overall decrease in glucagon secretion was »3-fold between glucose concentrations when islets were exposed to a HAGE diet (compare HAGE Fig. 1I and Fig. 1J ), islets derived from LAGE fed mice had a greater insulin/glucagon ratio under high glucose conditions (p D 0.02; Fig. 1K ). Islet glucagon content upon acid extraction showed no differences between groups (Fig. 1L) .
We next determined whether the expression of islet hormones differed between LAGE and HAGE offspring. Morphometric analyses of pancreatic islet immunohistochemical staining for insulin ( Fig. 2A) revealed a similar pattern of staining in both groups (Fig. 2B) . Determination of the reciprocal intensity 45 of insulin staining within islets, which is directly proportional to the amount of diaminobenzidine (DAB) present, also showed no difference between offspring exposed to a low or high AGE diet (Fig. 2C ). Proinsulin area in islets (Fig. 2D ) tended to be higher in LAGE mice, although this did not reach statistical significance (P D 0.06; Fig. 2E ). Consistent with insulin immunohistochemistry, no differences were observed in the intensity of proinsulin staining ( Fig. 2F ), resulting in an unchanged proinsulin to insulin ratio (data not shown). Glucagon localization (Fig. 2G ) demonstrated more alpha cells in islets of offspring exposed to a high AGE diet (P < 0.0001; Fig. 2H ) and greater glucagon intensity (P D 0.05; Fig. 2I ) in comparison to LAGE offspring. In situ hybridization (Fig. 2J ) demonstrated increased expression of the insulin gene Ins2 in islets from LAGE offspring as compared with HAGE mice (Fig. 2K ).
Exposure to low dietary AGEs from conception to early postnatal life reduced insulitis
Immune infiltration into pancreatic islets (insulitis) was next examined since it is postulated as a pathological feature of type 1 diabetes development. 40 Histopathology and chi-square test revealed that the severity of insulitis was significantly reduced in offspring exposed to a low AGE diet from conception (p D 0.0008; Fig. 3A , B), although there was no difference in the overall insulitis index (Fig. 3C ). There were no differences in islet number (p D 0.51; Fig. 3D 
C E), and na€ ıve
C conventional dendritic (cDC; K) and CD11c C CD11b ¡ plasmacytoid dendritic (pDC; L) cells within the pancreatic lymph node (pLN). Proportions of total splenic CD4 not promote an increase in the proportion of splenic CD4 C T cell na€ ıve or memory subsets compared to a high AGE environment ( Fig. 4N-P) . A similar increasing trend was observed in the proportion (p D 0.09) and variance (p D 0.03) of total splenic CD8 C T cells in LAGE offspring compared to HAGE diet-fed offspring (Fig. 4Q ). This shift corresponded with an increase in central memory T cells and a reduction effector memory T cells in LAGE mice, but these differences remained not significant (p D 0.09 and p D 0.06, respectively; Fig. 4S, T) . While low AGE dietary exposure in utero did not promote changes in the Treg, B cell or cDC subsets within the spleen (Fig. 4U-W) , higher proportions were observed in the pDC subset compared to high AGE diet-fed offspring (p D 0.008; Fig. 4X ).
Exposure to low dietary AGEs from conception to early postnatal life altered islet expression of the AGE, CML, and AGE receptors
In agreement with circulating levels of the clinically relevant AGE protein modification, CML 46 (Table 1) , the area of islet CML positivity in LAGE offspring was 2.8-fold lower compared to HAGE (p < 0.0001; Fig. 5A, B) , while the reciprocal intensity of CML did not differ between groups (Fig. 5C) . A proportion of NOD8.3 islet cells also expressed one of the AGE cell surface receptors, RAGE (Fig. 5D ). Although variable, there was less RAGE positivity in islets after exposure to a low AGE diet (p < 0.0001; Fig. 5E ). Quantification of the reciprocal DAB intensity also revealed considerable variation, particularly in the mice exposed to a low AGE diet, however, in comparison to a high AGE diet, intensity was reduced (p < 0.0001; Fig. 5F ). In pancreatic islets, the AGE clearance receptor, advanced glycation end product-receptor 1 (AGE-R1) (Fig. 5G ) was more abundant than RAGE (compare Fig. 5H and Fig. 5E ). Unlike anti-RAGE staining, however, low dietary AGEs did not affect AGE-R1 islet positivity (Fig. 5H) or stain intensity (Fig. 5I ).
Discussion
In a mouse model of accelerated type 1 diabetes, we demonstrate that prenatal and early postnatal exposure to low dietary AGEs increased glycemic hormone secretion and Ins2 gene expression, decreased islet immune cell infiltration, suggesting a reduced susceptibility to type 1 diabetes development. A low AGE diet from conception, pregnancy, and lactation (parental diet) through to early life (offspring postweaning diet) resulted in lower circulating concentrations of the AGE, CML, and reduced pancreatic expression of glucagon, CML and RAGE.
Environmental influences such as the diet consumed by parents prior to conception during pregnancy and lactation and that consumed by the offspring in postnatal life, may predispose individuals to metabolic abnormalities 47, 48 and chronic diseases such as diabetes. 49 Maternal diets and early infant feeding patterns have been associated with changes in type 1 diabetes-related autoantibodies in children. For example, lower consumption of vegetables by mothers, assessed by questionnaires immediately following birth, was associated with a higher risk of islet autoimmunity in children. 50 The introduction of gluten to newborns at less than 3 months of age also increased the risk of developing islet autoantibodies. 12 Similarly, more frequent consumption of cow's milk in childhood related to a greater chance of developing type 1 diabetes-associated autoantibodies. 51 However, no longitudinal study to date has investigated whether beta cell function and autoantibody development are impacted by parental dietary AGE intake, maternalinfant AGE transmission (in utero and lactation), or early life AGE consumption.
In line with this paucity of data, we randomized mating pairs of mice to one of two identical diets, that differed only in their AGE content and maintained offspring on the respective diet post-weaning. To our knowledge, this is the first time that the transgenic NOD8.3 mouse model was used to examine the impact of parental dietary programming of susceptibility factors for type 1 diabetes development, such as pancreatic islet hormone secretion and infiltration of immune cells. Low AGE feeding increased insulin, proinsulin and glucagon secretion from islets isolated from 28 day-old mice in the context of decreased islet immune infiltration. Further, the expression of the Ins2 gene was also increased by exposure to a low AGE diet. This finding is supported by previous studies where chronic administration of high AGE diets to healthy rodents impaired insulin secretion, expression and led to islet infiltration. 29, 30 Other studies in pancreatic beta cell lines have demonstrated that chronic exposure to high AGE concentrations decreases insulin secretion, most likely via increases in oxidative stress/reactive oxygen species production, 29, [52] [53] [54] by limiting the effectiveness of anti-oxidant pathways and enzymes. 29, 30 AGEs have also been shown to impair insulin secretion in otherwise healthy isolated islets. 29, 30, 54 Suppression in glucagon secretion was also shown following high glucose conditions in the LAGE offspring. One could speculate that, in the context of type 1 diabetes, a LAGE diet may therefore allow for more appropriate glucagon secretion given that glucagon secretion is physiologically a natural antagonist of insulin secretion. Indeed, we observed a higher insulin/glucagon ratio and lower alpha cell numbers in the islets of LAGE offspring in the context of higher insulin secretion as compared with the HAGE offspring. To our knowledge, the effects of AGEs on glucagon secretion are novel and have not been previously reported. We did not however, identify the mechanism responsible for the changes in glucagon and insulin secretion following a low AGE diet due to limited islet material. Although these increases in hormone secretion were not seen in the circulation, our findings are consistent with those from pre-diabetic individuals where fasting circulating insulin levels appear normal and abnormalities are only detected during stimulated secretion during glucose tolerance tests. 55 Thus, future work should investigate the mechanism by which low AGE dietary exposure impacts glucagon secretion at different stage of diabetes including non-diabetic control mice.
In 28 day-old NOD8.3 mice, we observed that prenatal and early postnatal reductions in dietary AGEs did not result in statistically significant changes in the proportions of CD4 C T cells, CD8 C T cells, Tregs, B cells or cDCs in the pancreatic lymph node and the spleen. However, there was a trend towards increases in CD4 C splenic T cells. This increase did not appear to be due to an elevation in antigen-experienced, CD44 C T cells and may be a consequence of higher T cell turnover, reductions in other immune cell subsets or represent a desirable cytokine environment for T cell proliferation. 56 Peppa et al., demonstrated that exposure to low dietary AGEs throughout prenatal development in the NOD/ShiLt mouse reduced pancreatic CD4
C T cell proportions which remained unresponsive to b-cell antigen stimulation. 28 On the other hand, splenic lymphocytes, which mainly expressed IL-10, remained responsive to antigenic stimuli. The authors speculated that low AGE environments allowed for the selective recruitment of T helper 2 (Th2) cells in the spleen, inhibiting autoreactive T cell recruitment to the inflamed pancreas. While further data would be required to confirm these processes in the NOD8.3 model, it is conceivable that AGEs can influence T cell polarization and T regulatory (Treg) cell function. 19 Previous reports suggest that na€ ıve human CD4 C T cells increase RAGE expression 57 and secretion of Th17 and Th1 cytokines, when exposed to AGEs. 37 AGEs also appear to reduce Treg suppression in vitro 57 and, in an animal model with impaired AGE clearance, high levels of circulating AGEs associated with reduced Treg numbers. 58 In addition, we also observed an increase in the proportions of pDCs in the spleen after low AGE exposure. This has not been previously described. pDCs are key mediators in autoimmunity and are involved in regulating T-cell mediated responses. 59 However, in the present study the function, proliferation or suppressive capacity of the T cell and antigen presenting cell subsets was not examined due to the limited material obtained from the four week old mice. These data however, do support previous studies suggesting that a low AGE environment may promote a more self-tolerant environment. However, whether an improvement in b-cell health and function causes a downmodulation of the immune system in early life represents an important research area to explore.
Transmission of AGEs between mother and baby occurs in utero and also during breastfeeding, and maternal AGE levels predict both insulin levels and insulin resistance in the 12-month-old infant. 25 In the present study, we did not measure maternal or paternal AGE levels, but circulating concentrations of the AGE modification, CML, was reduced in offspring exposed to low dietary AGEs, which is consistent with previous dietary studies. 31, 32, [60] [61] [62] CML was also lowered within the pancreas, which corresponded to a reduction in RAGE islet positivity. Indeed, in islet cell autoantibody positive children, elevations in circulating CML are an independent predictor of type 1 diabetes progression. 20 In the NOD/ShiLt mouse, Peppa et al., demonstrated a loss of diabetes protection after pups fed a low AGE diet in utero were substituted with a high AGE diet after weaning. 28 Hence, in future studies, it would be important to determine the relative contributions of maternal versus paternal dietary AGEs on infant susceptibility to type 1 diabetes, and disease progression, as well as the effect of AGE exposure in relation to cellular events including proliferation and apoptosis, during different critical periods of development (i.e. conception, prenatal, lactation and/ or post-weaning).
Similar to our short-term dietary intervention, a previous study in the related NOD/ShiLt mouse, showed that 50 weeks of a low AGE diet did not result in changes in body weight or blood glucose concentrations in females. 28 However, by 16 weeks of age, the F1 progeny prenatally exposed to a low AGE diet, had improved glucose homeostasis and less insulitis which translated to reduced diabetes incidence as compared to mice prenatally exposed to high AGEs. 28 Since we aimed to determine the effects of perinatal dietary AGE intervention on pancreatic islet function and immune system in early life, we sacrificed mice at 28 days of age. Indeed, following NOD8.3 offspring to diabetes diagnosis, post-AGE dietary intervention, and characterizing their islet function, immunology and disease pathology overtime, would be worthwhile in future studies.
For the first time, the effect low and high dietary AGE content at mating, in utero and post-weaning have been examined in a model of accelerated type 1 diabetes, the NOD8.3 mouse. A low AGE diet elevated hormonal secretion, decreased immune cell infiltration into the pancreatic islets of offspring and resulted in elevated proportions of pDCs in the spleen, in early life. These findings support future studies, which should examine the role of both prenatal and early life exposure to dietary AGEs in increasing risk for the development of type 1 diabetes.
Materials and methods
Preclinical study design
This study adhered to the National Health and Medical Research Council of Australia (NHMRC) guidelines and the protocol was approved by the Alfred Medical, Research and Education Precinct Animal Ethics committee (AMREP AEC) and the University of Queensland Animal Ethics committee. Six-week old female NOD/ShiLt mice and six-week old male NOD8.3 C were purchased from Walter and ELISA Hall Institute, Australia. Three females (6-weeks old) were housed with one male (6-weeks old) and each box was randomized to a diet either low (LAGE) or high (HAGE) in AGE content. The groupings remained together for one week for mating. The NOD8.3 strain express the TCRab rearranged transgenes derived from the H-2Kd-restricted, beta cell reactive, CD8 C T cell clone NY8.3 specific for IGRP [206] [207] [208] [209] [210] [211] [212] [213] [214] . 63 Female mice found to be pregnant were maintained on the same LAGE or HAGE regimen throughout pregnancy and lactation. Offspring were genotyped to identify female NOD8. 
Islet isolation
Islets were isolated from the juvenile NOD8.3 female mice as previously described. 29 Islets were also isolated from high AGE fed juvenile female C57Bl/6J mice as controls for insulin secretion. Briefly, the bile duct was cannulated and infused with 0.5 mg/ml ice-cold collagenase P (11213857001; Roche Biochemicals) in RPMI 1640 (11875119; Gibco) containing L-glutamine (25030081; Gibco), 100 U/mL penicillin, 100 mg/mL streptomycin (15140122; Gibco). The inflated pancreas was then excised and incubated in 10 ml of warm RPMI 1640 at 37 C for 20 min. Once the digestion was complete, the pancreas was disrupted by vigorous shaking, filtered through 500 mm mesh and washed three times in cold RPMI 1640 with centrifugation for 3 min, 1,000 rpm at 4 C. The pancreatic islets were separated from exocrine tissue by histopaque density gradient (10771; Sigma Aldrich). The hand-picked islets were rested overnight in RPMI 1640 medium containing L-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin and 5.0 mM glucose with 10% (vol/vol) heat-inactivated foetal bovine, in a 37 C humidified atmosphere of 95% air: 5% CO 2 .
Static assessment of islet hormone secretion
Handpicked islets (n D 4 mice/group) were pooled and 15 islets were plated per well (n D 6 wells). Hormone secretion assays were performed using low (2.8 mM) and high (20 mM) glucose concentrations, as previously described. 29 Briefly, isolated islets were washed once in Krebs-Ringer bicarbonate buffer (KRBB) with 2.8 mM glucose and pre-incubated for 30 min in 0.5 mL of the same buffer. This medium was collected and measured for basal levels of insulin and proinsulin secretion and stimulating levels of glucagon secretion. The islets were then incubated KRBB containing 20 mM glucose for another 30 min, in which the medium was collected and measured for glucose stimulated insulin and proinsulin secretion and the inhibition of glucagon secretion. After the test, islets were washed with PBS and lysed by acid ethanol to detect the total content of insulin, proinsulin and glucagon. Hormone concentrations in the incubation buffer and islet extract were measured using the mouse/rat insulin ELISA kit (EZRMI-13K; Linco Research), rat/mouse proinsulin ELISA kit (10-1232-01; Mercodia) and glucagon ELISA (10-1281-01; Mercodia). A stimulation index was calculated as the ratio of the insulin released during high glucose to the insulin release during low glucose treatment. The proinsulin to insulin ratio and insulin to glucagon ratio were calculated as the ratio of the proinsulin, insulin and glucagon release during high glucose conditions, respectively.
Biochemical assays
Fasting blood glucose was measured using a glucometer. Fasting plasma insulin (90080; Ultra-sensitive mouse insulin ELISA; Crystal Chem Inc.), plasma proinsulin (10-1232-01; Mercodia), plasma glucagon (10-1281-01; Mercodia) and fasting CML (STA-816; Oxiselect CML Competitive ELISA; Cell Biolabs Inc.) concentrations were determined using commercial ELISA kits according to the manufacturers' instructions.
Histological and immunohistochemical analysis
Pancreata were fixed in 10% neutral buffered formalin and embedded in paraffin. Serial sections (4 mm) were taken 100 mm apart. To determine the presence of islets sections (n D 2/mouse) were stained with hematoxylin and eosin using standard protocols. Insulitis of islets with 10 cells were semi-quantified using a previously published method. 64 Islet area per pancreas area was quantified using Visiopharm and anti-insulin stained immunohistochemical images described below. To determine proteins of interest, further pancreatic serial sections (n D 2, 100 mm apart) were blocked with 3% hydrogen peroxide (H1009; Sigma) and 10% donkey serum (S30-100; Merck Millipore), and stained with either primary antibodies (rat antiinsulin (MAB1417; R&D Systems); mouse anti-proinsulin (MAB13361; R&D Systems); rabbit anti-glucagon (A0565; DAKO); goat anti-RAGE (5484; Merck Millipore); rabbit anti-AGE-R1 (sc25558; Santa Cruz Biotechnology); rabbit anti-CML (ab27684; Abcam)) or used as negative controls (in blocking buffer; 10% donkey serum) overnight at 4 C. The presence of antigen was determined using secondary biotin-labelled antibodies, followed by avidin labelling (VEPK6100; Vector Laboratories) and 3,3 0 -diaminobenzidine detection (DAB; VESK4100; Vector Laboratories). Sections were counterstained with hematoxylin. Sections were imaged using an Olympus VS-ASW Slide Scanner light microscope (Olympus Australia Pty Ltd; Notting Hill, VIC, Australia) at a total magnification of x200. Quantitation of DAB positivity within each islet was completed in serial sections using Visiopharm Ò image analysis software (Olympus Australia Pty Ltd). To determine the quantity of antigen present from DAB C areas, the reciprocal DAB intensity was calculated, as previously described. 45 In Situ Hybridisation for Islet Ins2 Gene Expression
Gene expression of Ins2 in pancreatic islet sections was quantified in 7 mm paraffin embedded sections as previously described (Biol Reprod. 2012 Aug 23;87 (2):43). Briefly, a cDNA template for Ins2 was generated from pancreatic cDNA using PRIMERS, gel purified (Qiagen) and sequence verified (AGRF).
Digoxigenin (DIG) labeled cRNA probes were synthesized in accordance with manufacturer's directions (Roche). In situ hybridizations on paraffin-embedded sections were done as previously described. 65 A sense probe was used as a negative control. Quantification was performed using Visiopharm image software as per immunohistochemistry section above.
Flow cytometry
Pancreatic lymph nodes (pLN) and spleen were harvested from NOD8.3 mice and prepared as single-cell suspensions. Cell surface markers were assessed by staining the cells with pacific-blue conjugated anti-CD4 (558107), PerCP conjugated anti-CD8 (561092), to allophycocynin conjugated anti-CD44 (559250), fluorescein isothiocyanate conjugated anti-CD62 (561917), PECy7 conjugated anti-CD25 (552880), PECy7 conjugated CD19 (552854), APCCy7 conjugated anti-B220 (552094), PE conjugated anti-CD11b (553311), Pacific Orange-conjugated streptavidin against biotin-conjugated anti-CD11c (553800) (all antibodies 1:400; BD Bioscience). Intracellular staining with Foxp3 (560409; BD Biosciences) was performed according to the manufacturer's instructions. Flow cytometry was performed on FACSCanto II (BD Bioscience, San Jose, CA, USA) and data was analyzed with Flowjo analysis software (v10.0.8; BD Bioscience). Cells were gated on total lymphocytes and the plot was either gated on CD8
C and CD4 C , CD19
C and B220 C , or quadrant gates for CD11c and CD11b to determine CD11c
C
CD11b
C and CD11c 
Statistical analyses
Non-gaussian distributed data were analysed using a Mann-Whitney U test and are reported as median values with the interquartile range (IQR) and minimum and maximum values. Chi-squared test for trend was performed to analyze differences between insulitis frequencies. A value of p < 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism (GraphPad Software v.6, San Diego, CA). 
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